Peter J Wilkinson sold $439k of LH
SVP, Chief Accounting Officer at LABORATORY CORP OF AMERICA HOLDINGS. 1,420 shares at an average of $309.23, traded Aug 3, 2026, filed Aug 5, 2026.
Score components
- +15RoleOfficer
- +17Trade size$439k at market
- +20Share of holdings soldSold 77% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000920148-26-000172, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | SOpen-market sale Common Stock | -82 | $309.22 | $25k | 1,770 | Aug 5, 2026 |
| Aug 3, 2026 | MOption exercise Common Stock | +1,338 | $209.25 | $280k | 3,108 | Aug 5, 2026 |
| Aug 3, 2026 | SOpen-market sale Common Stock | -1,338 | $309.23 | $414k | 1,770 | Aug 5, 2026 |
| Aug 3, 2026 | MOption exercise Non-qualified Stock Optionsderivative | -1,338 | $0.00 | $0 | 0 | Aug 5, 2026 |
Related signals
Other insiders at LABORATORY CORP OF AMERICA HOLDINGS and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Kerrii B Anderson director | $954k 3,000 shares | -31% | |
| 45Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Adam H Schechter President & CEO | $1.5M 4,669 shares | -4% | |
| 49Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Amy B. Summy EVP, Chief Marketing Officer | $283k 924 shares | -12% | |
| 0Weak | LABORATORY CORP OF AMERICA HOLDINGS | Kathryn W Kyle EVP, Chief Legal Officer | $26k 92 shares | -2% | |
| 0Weak | LABORATORY CORP OF AMERICA HOLDINGS | Bryan T Vaughn EVP and President, Diagnostics | $67k 234 shares | -3% | |
| 12Weak | LABORATORY CORP OF AMERICA HOLDINGS | Kathryn W Kyle EVP, Chief Legal Officer | $201k 762 shares | -17% | |
| 30Weak | LABORATORY CORP OF AMERICA HOLDINGS | Adam H Schechter President & CEO | $1.5M 5,903 shares | -5% | |
| 20Weak | LABORATORY CORP OF AMERICA HOLDINGS | Jonathan C Meltzer EVP, Operations | $224k 839 shares | -19% | |
| 30Weak | LABORATORY CORP OF AMERICA HOLDINGS | Peter J Wilkinson SVP, Chief Accounting Officer | $436k 1,633 shares | -47% | |
| 65Notable | LABORATORY CORP OF AMERICA HOLDINGS | Adam H Schechter President & CEO | $2.4M 8,705 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.